Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXION. - Kloka, Jan; Friedrichson, Benjamin; Dauth, Stephanie; Foldenauer, Ann Christina; Bulczak-Schadendorf, Anita; Vehreschild, Maria J. G. T.; Matos, Francisco Maio; Riera-Mestre, Antoni; van Asselt, Antoinette D. I.; De Robertis, Edoardo; Juskeviciene, Vilma Traskaite; Meybohm, Patrick; et al. (Trials, 2022)